The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets

DOI: https://doi.org/10.2147/dmso.s415934

2024-06-14

Diabetes Metabolic Syndrome and Obesity Targets and Therapy

Abstract:Joshua Reed, Stephen C Bain, Venkateswarlu Kanamarlapudi Institute of Life Science, Medical School, Swansea University, Swansea, SA2 8PP, UK Correspondence: Venkateswarlu Kanamarlapudi, Institute of Life Science, Medical School, Swansea University, Swansea, SA2 8PP, UK, Tel +44 1792 295012, Fax +44 1792 602148, Email In healthy humans, the complex biochemical interplay between organs maintains metabolic homeostasis and pathological alterations in this process result in impaired metabolic homeostasis, causing metabolic diseases such as diabetes and obesity, which are major global healthcare burdens. The great advancements made during the last century in understanding both metabolic disease phenotypes and the regulation of metabolic homeostasis in healthy individuals have yielded new therapeutic options for diseases like type 2 diabetes (T2D). However, it is unlikely that highly desirable more efficacious treatments will be developed for metabolic disorders until the complex systemic regulation of metabolic homeostasis becomes more intricately understood. Hormones produced by pancreatic islet beta-cells (insulin) and alpha-cells (glucagon) are pivotal for maintaining metabolic homeostasis; the activity of insulin and glucagon are reciprocally correlated to achieve strict control of glucose levels (normoglycaemia). Metabolic hormones produced by other pancreatic islet cells and incretins produced by the gut are also crucial for maintaining metabolic homeostasis. Recent studies highlighted the incomplete understanding of metabolic hormonal synergism and, therefore, further elucidation of this will likely lead to more efficacious treatments for diseases such as T2D. The objective of this review is to summarise the systemic actions of the incretins and the metabolic hormones produced by the pancreatic islets and their interactions with their respective receptors. Keywords: type 2 diabetes, obesity, insulin, glucagon, GLP-1, GLP-1R, incretin, metabolism Maintaining metabolic homeostasis is essential in all living organisms, as it provides energy in the form of adenosine trisphosphate (ATP) required for cellular processes to proceed. 1,2 In healthy humans, the complex biochemical interplay between organs maintains metabolic homeostasis. 3,4 Disorders that affect this biochemical interplay, such as diabetes and obesity, result in impaired metabolic homeostasis in individuals. 4,5 The main hormones that regulate metabolic homeostasis are insulin and glucagon, which are secreted into circulation as required by islet-beta and alpha cells, respectively. 6,7 Insulin is considered to be an anabolic hormone due to its ability to positively influence glycogen, protein, fatty acid and triacylglycerol synthesis in tissues, and glucagon is considered to be a catabolic hormone due to its ability to promote the breakdown of the same in tissues. 4,8 The activity of both insulin and glucagon, which play a vital role in maintaining metabolic homeostasis, is required to accomplish strict control of glucose levels (normoglycaemia). 6,7,9 It has also been elucidated that other hormones produced by other pancreatic islet cells and the gut are crucial for maintaining metabolic homeostasis, in addition to insulin and glucagon. 10–12 Glucose when administered orally promotes significantly higher pancreatic insulin secretion than when it is administered intravenously, which is termed the "incretin effect". 11,13 This led to the identification of two gut hormones that produce the incretin effect: glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP) which are produced by L and K cells of the gut, respectively. 14,15 The incretin hormones GLP-1 and GIP are confirmed to be crucial for maintaining metabolic homeostasis via augmentation of insulin secretion from islet beta-cells. The incretin effect is responsible for 60–70% of insulin secretion after glucose consumption in healthy individuals. 16,17 Thus, the activity of the pancreatic islets and the L and K cells are closely coupled to maintain metabolic homeostasis in humans. Obesity and type 2 diabetes (T2D) are the main metabolic disorders given their global prevalence and economic burden. 18 Globally, approximately (∼) 382 million patients were estimated to have diabetes in 2013 and ∼600 million individuals were classified as obese (BMI≥30 kg/m 2 ) in 2014 and these numbers will increase in the future. 18,19 Inadequate energy spending together with excessive energy intake and storage induces obesity, which causes gain of weight. 18 Whilst obesity manifests due to excessive diets and sedentary lifestyles, it has been established that this condition also has a genetic aetiology in some individuals, usually involving the genes invo -Abstract Truncated-

endocrinology & metabolism